Like tens of thousands of Massachusetts residents, community college professor Carolyn McGrath has been paying for medicine ...

A new paper by the Institute for Clinical and Economic Review (ICER) looks at the cost-effectiveness versus affordability ...

Orforglipron, which could become the first GLP-1 pill — a much more convenient option — is a step closer to hitting the ...

It is also testing Zepbound in other conditions linked to obesity, such as MASH (liver disease), chronic kidney disease, and heart failure. Affordability Strategy: LillyDirect and Price Reductions ...

For Zepbound, developed by Lilly, it's the same drug and administered in the same dose as Mounjaro, which is used to treat diabetes. Advertisement Advertisement The Biden proposal would have ...

Some of the more than a dozen states that cover the high cost of GLP-1 drugs like Wegovy, Ozempic and Zepbound through ...

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there’s little information on the drugs ...

Not only do people wake up tired and groggy, but it can also lead to serious health problems including heart ... also known as Mounjaro or Zepbound. It's FDA approved to manage diabetes and ...